Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-29 @ 2:24 AM
Study NCT ID:
NCT01968668
Status:
COMPLETED
Last Update Posted:
2021-07-16
First Post:
2013-10-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-21
First Submit QC Date:
None
Study First Post Date:
2013-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-15
Last Update Post Date:
2021-07-16
Last Update Post Date Type:
ACTUAL